1. Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
- Author
-
Hugo Rodríguez-Zanella, Claudia Lerma, Sergio Mora-Canela, Victor Manuel Anguiano-Álvarez, Raúl Izaguirre-Ávila, Gustavo Rojas-Velasco, Flavio A Grimaldo-Gómez, Samuel Ramirez-Marroquin, Ángel Ramos-Enríquez, Adriana Torres-Machorro, Edgar García-Cruz, and Evelyn Cortina-de la Rosa
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Deep vein ,Letter to the Editors-in-Chief ,aPTT, activated partial thromboplastin time ,Autopsy ,030204 cardiovascular system & hematology ,Asymptomatic ,VTE, Venous thromboembolism ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,PT, prothrombin time ,medicine ,cardiovascular diseases ,Prospective cohort study ,LDH, Lactate Dehydrogenase ,business.industry ,Critically ill ,HS-CRP, High sensitivity C-Reactive protein ,ASA, Acetylsalicylic acid ,Hematology ,medicine.disease ,Thrombosis ,LMWH, Low molecular weight heparin ,DD, D-Dimer ,ADP, adenosine diphosphate ,Venous thrombosis ,ICU, Intensive care unit ,medicine.anatomical_structure ,UFH, Unfractionated heparin ,030220 oncology & carcinogenesis ,medicine.symptom ,DVT, Deep vein thrombosis ,business - Abstract
Highlights • Clinical signs are not useful for detecting DVT in critically ill COVID-19 patients • DVT occurs despite full dose anticoagulation in critically ill COVID-19 patients • Severe COVID-19 patients present a high prevalence of bilateral DVT
- Published
- 2020